FBLN1 and diabetes mellitus: Considering that myocardial fibulin-1 mRNA levels have been shown to increase in an animal model of cardiomyopathy11 and in a human model of the arterial wall in diabetes,5 it is possible that different cardiovascular pathologic conditions may augment tissue fibulin-1 to be released into the blood.